(Q43573400)

English

CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA).

scientific article published in February 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA). (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

B Hanke

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

C Riedel

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

S Lampert

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

K Happich

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

P Martus

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

H Parsch

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

B Himmler

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

W Hohenberger

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

E G Hahn

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A Wein

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

221-226

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly therapy with folinic acid and high-dose 5-fluorouracil 24-hour infusion in previously untreated patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvements in palliative treatment of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of colorectal carcinoma patients by repeated CEA radioimmunoassay

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

CEA Monitoring of Palliative Treatment for Colorectal Carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA 19.9 and CA 125 in advanced colorectal cancer (ACC)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring the accuracy of diagnostic systems

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomised trial of early cytotoxic therapy for recurrent colorectal carcinoma detected by serum CEA

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008378412533

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008378412533

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43573400&oldid=2101215747"